icrf 193 has been researched along with 5'-adenylyl (beta,gamma-methylene)diphosphonate in 1 studies
Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (5'-adenylyl (beta,gamma-methylene)diphosphonate) | Trials (5'-adenylyl (beta,gamma-methylene)diphosphonate) | Recent Studies (post-2010) (5'-adenylyl (beta,gamma-methylene)diphosphonate) |
---|---|---|---|---|---|
155 | 0 | 30 | 296 | 0 | 17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andoh, T; Berger, JM; Ishida, R; Roca, J; Wang, JC | 1 |
1 other study(ies) available for icrf 193 and 5'-adenylyl (beta,gamma-methylene)diphosphonate
Article | Year |
---|---|
Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Binding Sites; Diketopiperazines; DNA Topoisomerases, Type II; DNA, Circular; DNA, Fungal; Molecular Structure; Piperazines; Saccharomyces cerevisiae; Serine Endopeptidases; Topoisomerase II Inhibitors | 1994 |